Umar Alam
Neurology · Richmond, VANPI 1295112886
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 287 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $3,382 and has fallen 98.0% since, to $66 in 2023.
Across 287 payments — averaging $16.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$801
- Biogen$603
- Biohaven Pharmaceuticals, Inc.$512
- UCB, Inc.$347
- Novartis$335
- CSL Behring$238
- plus $2K from 23 others
What the payments were for
- Food & beverage$4,604100%
- Education$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 72 | $801 |
| Biogen | 44 | $603 |
| Biohaven Pharmaceuticals, Inc. | 22 | $512 |
| UCB, Inc. | 17 | $347 |
| Novartis | 17 | $335 |
| CSL Behring | 19 | $238 |
| Amneal Pharmaceuticals LLC | 11 | $190 |
| Sunovion Pharmaceuticals Inc. | 9 | $189 |
| Lundbeck LLC | 7 | $138 |
| AstraZeneca | 5 | $109 |
| Neurocrine Biosciences, Inc. | 5 | $97 |
| Lilly USA, LLC | 5 | $97 |
| Neurelis, Inc. | 7 | $96 |
| Supernus Pharmaceuticals, Inc. | 4 | $83 |
| Eisai Inc. | 5 | $82 |
| Bristol Myers Squibb | 4 | $81 |
| Amgen | 4 | $80 |
| Livanova USA, Inc. | 5 | $76 |
| Teva Pharmaceuticals USA, Inc. | 3 | $61 |
| Currax Pharmaceuticals LLC | 4 | $61 |
| Sanofi | 3 | $59 |
| Avanir Pharmaceuticals, Inc. | 3 | $52 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $50 |
| Mallinckrodt Hospital Products Inc. | 2 | $50 |
| Johnson & Johnson | 3 | $47 |
| SK Life Science, Inc. | 2 | $34 |
| E.r. Squibb & Sons, L.L.C. | 1 | $22 |
| Upsher-smith Laboratories LLC | 1 | $19 |
| EMD Serono, Inc. | 1 | $15 |
How this compares
$4,624 in reported general payments places this provider in the 65th percentile of 474 neurology providers in Virginia.
Other neurology in Richmond
- Catherine HamRichmond$603K
- Daniel HardyRichmond$382K
- Myla GoldmanRichmond$132K
- Alan SchulmanRichmond$104K
- Warren FeltonRichmond$96K
- John WittmanRichmond$61K
- Matthew BoyceRichmond$56K
- Leslie CloudRichmond$46K
- Jonathan BekensteinRichmond$37K
- Jessica LehositRichmond$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.